These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 3708625)
1. Apparent myocardial ischemia associated with vinblastine administration. Subar M; Muggia FM Cancer Treat Rep; 1986 May; 70(5):690-1. PubMed ID: 3708625 [No Abstract] [Full Text] [Related]
2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
3. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma. Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988 [TBL] [Abstract][Full Text] [Related]
4. Acute coronary syndrome secondary to fluorouracil infusion. Lu JI; Carhart RL; Graziano SL; Gajra A J Clin Oncol; 2006 Jun; 24(18):2959-60. PubMed ID: 16782933 [No Abstract] [Full Text] [Related]
5. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
6. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer. Chang AY; DeVore R; Johnson D Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin. Dhingra HM; Valdivieso M; Booser DJ; Umsawasdi T; Carr DT; Chiuten DF; Murphy WK; Issell BF; Spitzer G; Farha P Cancer Treat Rep; 1984 Apr; 68(4):671-3. PubMed ID: 6538811 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma. Mulatero C; McClaren BR; Mason M; Oliver RT; Gallagher CJ Br J Cancer; 2000 Dec; 83(12):1612-6. PubMed ID: 11104554 [TBL] [Abstract][Full Text] [Related]
9. An active chemotherapy regimen for squamous cell lung cancer. Cohen MH; Johnston-Early A; Citron ML; Krasnow SH; Fossieck BE Cancer Treat Rep; 1984 Mar; 68(3):475-9. PubMed ID: 6200219 [TBL] [Abstract][Full Text] [Related]
10. [Myocardial infarction and vinorelbine. Report of a case]. Dubos C; Prévost JN; Brun J; Rousselot P Rev Mal Respir; 1991; 8(3):299-300. PubMed ID: 1857829 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study]. König HJ; Arnold E; Walter M; Sander U Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study. Tsavaris N; Kosmas CH; Vadiaka M; Kontos A; Katsorida M; Dimitrakopoulos A; Zerai A; Koufos CH J Exp Clin Cancer Res; 2001 Mar; 20(1):29-34. PubMed ID: 11370826 [TBL] [Abstract][Full Text] [Related]
13. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Nguyen-Ho P; Kleiman NS; Verani MS Can J Cardiol; 2003 Mar; 19(3):300-2. PubMed ID: 12677287 [TBL] [Abstract][Full Text] [Related]
14. Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience. Goedhals L; Falkson G; Smith BL; Falkson CI; Gasmi J; Lategan A; Burillon JP; His P Anticancer Res; 2005; 25(3c):2489-92. PubMed ID: 16080481 [TBL] [Abstract][Full Text] [Related]
15. [Coronary disease and vinorelbine]. Ruffenach M; Missler J; Meier M; Salen JM Rev Pneumol Clin; 1994; 50(2):94. PubMed ID: 7839061 [No Abstract] [Full Text] [Related]
16. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial. Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183 [TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma. Hutcheon AW; Palmer JB; Pratt MA; Clark RA Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231 [No Abstract] [Full Text] [Related]
18. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV). Ruckdeschel JC; Day R; Weissman CH; Stolbach LL; Creech RH Cancer Treat Rep; 1984 Nov; 68(11):1325-9. PubMed ID: 6388831 [TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma. Viallet J; Brassard MA; Souhami L; Ayoub J; Del Vecchio P; Kreisman H; Guerra J; Gruber J; Langleben A; Hohneker J; Rousseau P Cancer; 1999 Jun; 85(12):2562-9. PubMed ID: 10375103 [TBL] [Abstract][Full Text] [Related]
20. [Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin]. Takahashi T; Mori K; Suga Y; Tominaga K Gan To Kagaku Ryoho; 1993 Sep; 20(12):1873-5. PubMed ID: 8397491 [No Abstract] [Full Text] [Related] [Next] [New Search]